About Variations
About V1
Finance Leadership Without Boundaries
25+ years driving shareholder value and strategic transformation across biopharmaceuticals.
Yasser Hazzaa
CFO Consultant & Board Member
Education
MBA, Maastricht School
Credentials
CPA (California)
From engineering roots to CFO leadership — I bridge technical complexity with financial clarity.
My career spans Bristol-Myers Squibb ($17B FP&A leadership) to MannKind Corporation (supporting ~600% market cap growth). Today I serve as Board Member at TesoRx Pharma and Lipac Oncology, guiding audit and finance strategy.
I operate across 30+ markets with fluency in English and Arabic, bringing global perspective to capital strategy, FP&A transformation, and board-ready reporting.
25+
Years Experience
$17B
Business Led
30+
Markets Served
600%
Market Cap Growth
About V2
Finance LeadershipBuilt on Results
25+ years transforming biopharma finance — from $17B FP&A leadership at Bristol-Myers Squibb to 600% market cap growth at MannKind.
"My engineering background gives me a systems-thinking approach to finance — connecting operational complexity with strategic clarity."
Yasser Hazzaa
MBA, CPA • Board Member
Yasser Hazzaa
CFO Consultant
25+
Years Experience
$17B
Business Led
30+
Global Markets
600%
Market Cap Growth
Current Board Positions
Strategic Clarity
Engineering mindset applied to financial leadership
Governance Excellence
Board-level audit and risk oversight
Value Creation
Proven track record of market cap growth
Global Scale
Leadership across 30+ international markets
About V3
Global Finance Leadership
Engineering foundation. Financial mastery. 25+ years driving transformation.
Yasser Hazzaa
CFO Consultant & Board Advisor
Education
MBA, Maastricht School
Credentials
CPA (California)
Location
Oak Park, CA
Languages
English, Arabic (Fluent)
Career Highlights
$17B
Business Led at BMS
600%
Market Cap Growth
30+
Markets Served
25+
Years Experience
"My engineering mindset brings systems-thinking to financial strategy."
Recent Timeline
2025–Present
Board Member
TesoRx Pharma & Lipac Oncology
2017–2025
VP Finance
MannKind Corporation
2011–2016
Director, Corporate FP&A
Bristol-Myers Squibb
2009–2010
Associate Director Finance – Europe
Bristol-Myers Squibb
About V4
FinanceLeadership
Engineering foundation. Financial mastery. Proven results across biopharma and global markets.
Yasser Hazzaa
CFO Consultant
25+
Years
$17B
Led
30+
Markets
600%
Growth
My journey began in engineering — developing the analytical rigor and systems-thinking that now defines my approach to financial leadership. This unique foundation allows me to translate complex operational challenges into clear strategic direction.
From directing FP&A for a $17B business at Bristol-Myers Squibb to serving as VP Finance at MannKind Corporation through 600% market cap growth, I have consistently delivered in high-stakes environments. Today, I bring this experience to boardrooms at TesoRx Pharma and Lipac Oncology.
Key Achievements
- Led FP&A for $17B business at Bristol-Myers Squibb
- Supported 600% market cap growth at MannKind Corporation
- Built global FP&A community of 150+ professionals
- Board oversight for clinical-stage biopharma companies
- Finance leadership across 30+ EMEA markets